Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency.
about
Mechanism of the Dual Activities of Human CYP17A1 and Binding to Anti-Prostate Cancer Drug Abiraterone Revealed by a Novel V366M Mutation Causing 17,20 Lyase Deficiency.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Mechanism of the Dual Activiti ...... ausing 17,20 Lyase Deficiency.
@en
Mechanism of the Dual Activiti ...... ausing 17,20 Lyase Deficiency.
@nl
type
label
Mechanism of the Dual Activiti ...... ausing 17,20 Lyase Deficiency.
@en
Mechanism of the Dual Activiti ...... ausing 17,20 Lyase Deficiency.
@nl
prefLabel
Mechanism of the Dual Activiti ...... ausing 17,20 Lyase Deficiency.
@en
Mechanism of the Dual Activiti ...... ausing 17,20 Lyase Deficiency.
@nl
P2093
P2860
P356
P1433
P1476
Mechanism of the Dual Activiti ...... ausing 17,20 Lyase Deficiency.
@en
P2093
Adam Zalewski
Bernhard Dick
Brigitte M Frey
Christa E Flück
Laura Audí
Mónica Fernández-Cancio
Núria Torán
Raquel Monné
P2860
P356
10.3390/PH11020037
P577
2018-04-29T00:00:00Z